About this Research Topic
In recent years, there has been a significant increase in the number of zoonotic influenza cases, particularly avian influenza, where the influenza virus has crossed the barrier from infected birds to humans without the need for an intermediate host. This rise in spillovers into the human population is alarming due to the almost negligible immunity humans have to these zoonotic influenza viruses, posing a significant risk of a pandemic if inter-human transmission becomes established. The genetic diversity of avian influenza viruses, combined with their ability to rapidly mutate, makes them particularly concerning. Additionally, changes in global agricultural practices, increased human-animal interactions, and environmental changes contribute to the heightened risk of spillover events. Given these factors, it is crucial to be prepared to handle any future influenza pandemic effectively.
A multi-faceted approach is required to prepare for any eventual Zoonotic influenza outbreak in the human population. These approaches include: (a) Modeling Virus Transmission:Understanding the dynamics of virus spread within human and animal populations is essential. Developing detailed models to predict potential outbreak scenarios and inform public health strategies. (b) Vaccine Development:Creating broader vaccines that can establish immunity in the human population, offering protection against both pandemic influenza viruses and established seasonal human influenza viruses.(c) Therapeutic Development:Developing therapeutic entities to treat the disease manifestations post-infection. Researching new antiviral compounds and re-purposing existing drugs to treat influenza effectively. (d) Public Health Measures:Strengthening global surveillance systems to detect and respond to outbreaks swiftly. Educating the public about preventive measures, such as hygiene practices and the importance of vaccination. Enhancing healthcare infrastructure to manage increased patient loads during outbreaks. Implementing stricter regulations and monitoring of agricultural practices to minimize the risk of virus transmission from animals to humans. Enhancing bio-security measures in farms, markets, and other places where human-animal interactions occur. Monitoring the health of wildlife populations that may serve as reservoirs for zoonotic viruses.
This Research Topic welcomes the submission of papers focused on the mathematical modeling of zoonotic influenza virus transmission, the design of vaccine antigens for zoonotic influenza, the development of therapeutics to treat post-infection sequelae, and public health measures to contain the infection. By taking a comprehensive and proactive approach that includes these strategies, we can improve our preparedness for future zoonotic influenza outbreaks and mitigate their impact on global health. Effective preparedness not only protects human health but also helps maintain economic stability and social order during potential pandemics.
Dr. Sneha Vishwanath declares that she is named on 6 patents related to influenza and coronavirus vaccines, affiliated with the University of Cambridge.
A multi-faceted approach is required to prepare for any eventual Zoonotic influenza outbreak in the human population. These approaches include: (a) Modeling Virus Transmission:Understanding the dynamics of virus spread within human and animal populations is essential. Developing detailed models to predict potential outbreak scenarios and inform public health strategies. (b) Vaccine Development:Creating broader vaccines that can establish immunity in the human population, offering protection against both pandemic influenza viruses and established seasonal human influenza viruses.(c) Therapeutic Development:Developing therapeutic entities to treat the disease manifestations post-infection. Researching new antiviral compounds and re-purposing existing drugs to treat influenza effectively. (d) Public Health Measures:Strengthening global surveillance systems to detect and respond to outbreaks swiftly. Educating the public about preventive measures, such as hygiene practices and the importance of vaccination. Enhancing healthcare infrastructure to manage increased patient loads during outbreaks. Implementing stricter regulations and monitoring of agricultural practices to minimize the risk of virus transmission from animals to humans. Enhancing bio-security measures in farms, markets, and other places where human-animal interactions occur. Monitoring the health of wildlife populations that may serve as reservoirs for zoonotic viruses.
This Research Topic welcomes the submission of papers focused on the mathematical modeling of zoonotic influenza virus transmission, the design of vaccine antigens for zoonotic influenza, the development of therapeutics to treat post-infection sequelae, and public health measures to contain the infection. By taking a comprehensive and proactive approach that includes these strategies, we can improve our preparedness for future zoonotic influenza outbreaks and mitigate their impact on global health. Effective preparedness not only protects human health but also helps maintain economic stability and social order during potential pandemics.
Dr. Sneha Vishwanath declares that she is named on 6 patents related to influenza and coronavirus vaccines, affiliated with the University of Cambridge.
Keywords: Zoonotic influenza, One health approaches, Pandemic preparedness, Vaccines Viral therapeutics, Disease transmission modeling, Public health measures
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
